Leptin levels in patients with psoriasis: A meta-analysis

Clinical and Experimental Dermatology

Volumn 38, Issue 5, 2013, Pages 478-483

  Zhu, K J ^a   Zhang, C ^b   Li, M ^c   Zhu, C Y ^a   Shi, G ^a   Fan, Y M ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

ARTICLE; BLOOD SAMPLING; HORMONE BLOOD LEVEL; HUMAN; PRIORITY JOURNAL; PSORIASIS; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

BIOLOGICAL MARKERS; HUMANS; LEPTIN; PSORIASIS; RISK FACTORS;

EID: 84879241693     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12171     Document Type: Article

References (26)

1. Schon MP, Boehncke WH,. Psoriasis. N Engl J Med 2005; 352: 1899-912.
2. Shipman AR, Millington GW,. Obesity and the skin. Br J Dermatol 2011; 165: 743-50.
3. Setty AR, Curhan G, Choi HK,. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med 2007; 167: 1670-5.
4. Sterry W, Strober BE, Menter A,. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol 2007; 157: 649-55.
5. Otero M, Lago R, Lago F, et al,. Leptin, from fat to inflammation: old questions and new insights. FEBS Lett 2005; 579: 295-301.
6. Matarese G, Moschos S, Mantzoros CS,. Leptin in immunology. J Immunol 2005; 174: 3137-42.
7. Shimizu H, Shimomura K, Negishi M, et al,. Circulating concentrations of soluble leptin receptor: influence of menstrual cycle and diet therapy. Nutrition 2002; 18: 309-12.
8. Heimburger O, Lonnqvist F, Danielsson A, et al,. Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 1997; 8: 1423-30.
9. Considine RV, Sinha MK, Heiman ML, et al,. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-5.
10. Johnston A, Arnadottir S, Gudjonsson JE, et al,. Obesity in psoriasis. leptin and resistin as mediators of cutaneous inflammation. Br J Dermatol 2008; 159: 342-50.
11. Takahashi H, Tsuji H, Takahashi I, et al,. Plasma adiponectin and leptin levels in Japanese patients with psoriasis. Br J Dermatol 2008; 159: 1207-8.
12. Gerdes S, Osadtschy S, Rostami-Yazdi M, et al,. Leptin, adiponectin, visfatin and retinol-binding protein-4-mediators of comorbidities in patients with psoriasis? Exp Dermatol 2012; 21: 43-7.
13. Stroup DF, Berlin JA, Morton SC, et al,. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
14. Egger M, Davey Smith G, Schneider M, et al,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
15. Begg CB, Mazumdar M,. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101.
16. Coimbra S, Oliveira H, Reis F, et al,. Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy. J Eur Acad Dermatol Venereol 2010; 24: 1386-94.
17. Senturk N, Aydin F, Birinci A, et al,. Investigation for the leptin 1 and LEP G2548A gene polymorphism in psoriasis. Eur J Dermatol 2008; 18: 343-4.
18. Wang Y, Chen J, Zhao Y, et al,. Psoriasis is associated with increased levels of serum leptin. Br J Dermatol 2008; 158: 1134-5.
19. Kaur S, Zilmer K, Leping V, et al,. The levels of adiponectin and leptin and their relation to other markers of cardiovascular risk in patients with psoriasis. J Eur Acad Dermatol Venereol 2011; 25: 1328-33.
20. Cerman AA, Bozkurt S, Sav A, et al,. Serum leptin levels, skin leptin and leptin receptor expression in psoriasis. Br J Dermatol 2008; 159: 820-6.
21. Chen YJ, Wu CY, Shen JL, et al,. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome. Arch Dermatol 2008; 144: 1571-5.
22. Nakajima H, Nakajima K, Nagano Y, et al,. Circulating level of chemerin is upregulated in psoriasis. J Dermatol Sci 2010; 60: 45-7.
23. Abdel Hay RM, Rashed LA,. Association between the leptin gene 2548G/A polymorphism, the plasma leptin and the metabolic syndrome with psoriasis. Exp Dermatol 2011; 20: 715-19.
24. Enany B, El Zohiery AK, Elhilaly R, et al,. Carotid intima-media thickness and serum leptin in psoriasis. Herz 2012; 37: 527-33.
25. Boehncke WH, Boehncke S, Schon MP,. Managing comorbid disease in patients with psoriasis. BMJ 2010; 340: b5666.
26. Hercogova J, Ricceri F, Tripo L, et al,. Psoriasis and body mass index. Dermatol Ther 2010; 23: 152-4. Education